http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd6d164b52eb10c7fb5e62fca4a24ccb
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Salgia |
| name | Ravi Salgia |
| given-name | Ravi |
| organization-name | City of Hope Comprehensive Cancer Center, Duarte, California Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA Section of Hematology/Oncology Department of Medicine University of Chicago Chicago Illinois Professor of Medicine, Director, Thoracic Oncology Program, Department of Medicine, Section of Hematology/Oncology, Pritzker School of Medicine, University of Chicago, 5841 South Maryland Ave., Chicago, IL 60637, USA Authors' Affiliations: 1Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois; 2Genentech, Inc., South San Francisco, California; and 3Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, New Jersey 1Medicine, Departments of Department of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA 4Department of Medical Oncology and Experimental Therapeutics, Comprehensive Cancer Center, City of Hope, Duarte, California. From the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD; Department of Medicine, University of Chicago, Chicago, IL; Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham, NC; Helen F. Graham Cancer Center, Christiana Care Health Services Inc, Wilmington, DE; Division of Hematology/Oncology, Department of Medicine and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; the Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and the Department of Medicine, University of Chicago, Pritzker School of Medicine, IL. 2Adult Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts; Section of Hematology/OncologyDepartment of MedicineUniversity of ChicagoChicagoIllinoisUSA 1Department of Medicine, The University of Chicago, Chicago, Illinois.; 8The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Department of Medicine, the University of Chicago, Chicago, Illinois; Laboratory of Immunobiology and Division of Adult Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115 2Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, Illinois Department of Medicine, Section of Hematology & Oncology, Chicago, IL, USA The University of Chicago Hospitals, Chicago, IL Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, United States. Electronic address: rsalgia@coh.org. 9The University of Chicago School of Medicine, Chicago, Illinois. Authors' Affiliations: 1Section of Hematology/Oncology, Department of Medicine, 2Section of Urology, Department of Surgery; 3Biostatistics Core, Department of Heath Studies; 4Department of Pathology, University of Chicago; 5Department of Pharmacology, University of Illinois at Chicago, Chicago, Illinois; 6Department of Urology, University of Michigan School of Medicine, Ann Arbor, Michigan; 7Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York; 8Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; and 9Division of Hematology/Oncology, Department of Medicine and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles Departments of Medical Oncology City of Hope Comprehensive Cancer Center and National Medical Center Duarte California USA Department of Medical Oncology and Therapeutic Research, City of Hope, Duarte, CA, USA 7Division of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois. University of Chicago Chicago Illinois Division of Adult Oncology and Thoracic Oncology Program, Department of Medicine, Dana-Farber Cancer Institute, Brigham and Women#x2019;s Hospital and Harvard Medical School Authors' Affiliations: Departments of 1Human Oncology and 2Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, 3Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin; and 4Division of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois Jochen K. Lennerz, A. John Iafrate, Kristin Bergethon, Gregory Y. Lauwers, Daniel A. Haber, Eunice L. Kwak, Jeffrey W. Clark, Allison Ackerman, Massachusetts General Hospital/Harvard Medical School, Boston, MA; Michael Michael, Stephen B. Fox, Benjamin J. Solomon, Peter MacCallum Cancer Centre, Melbourne, Australia; James G. Christensen, Keith D. Wilner, Pfizer, La Jolla, CA; Ravi Salgia, University of Chicago, Chicago, IL; and Yung-Jue Bang, Seoul National University Hospital, Seoul, South Korea. Authors' Affiliations: Departments of 1Medicine and 2Pathology, The University of Chicago, Chicago, Illinois Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center , Duarte, CA , USA Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010‑3000, USA City of Hope Comprehensive Cancer Center, Los Angeles, CA, USA Department of Medical Oncology, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, USA Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago IL 3Section of Hematology/Oncology, Department of Medicine and University of Chicago Cancer Research Center, University of Chicago, Chicago, Illinois; Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, USA;Harvard Medical School, 44 Binney Street, 02115, Boston, MA Department of Medicine, University of Chicago, Chicago, Illinois, USA Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. 1Section of Hematology/Oncology, Department of Medicine, University of Chicago Cancer Research Center, University of Chicago Medical Center, Pritzker School of Medicine, Chicago, Illinois; Authors' Affiliations: 1Section of Hematology/Oncology, Department of Medicine, Departments of 2Pathology and 3Surgery, The University of Chicago, Chicago, Illinois; 4Division of Hematology and Pathology, Department of Medicine, University of Southern California, Los Angeles, California; 5Department of Surgery and Science, University of Toyama, Toyama, Japan; and 6Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, Maryland Department of Medicine, The University of Chicago, Chicago, Illinois, USA Department of Medicine, The University of Chicago, Section of Hematology/Oncology and Cancer Center, Chicago, Illinois, USA Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California, USA Department of Medical Oncology and Therapeutics Research From the Departments of Medicine, Section of Hematology/Oncology (Drs Faoro and Salgia), Pathology (Drs Hutto, Salgia, El-Zayaty, Krausz, and Husain), Surgery (Dr Ferguson), and Radiology (Dr Armato), and the University of Chicago Cancer Research Center (Dr Salgia), University of Chicago, Chicago, Ill; and the Departments of Pathology and Laboratory Medicine (Dr Cheney) and Epidemiology (Dr Reid) 7Department of Medicine, Division of Hematology-Oncology, University of Chicago, Chicago, Illinois Departments of Adult Oncology and Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts, USA City of Hope, Duarte, California Authors' Affiliations: Departments of 1Medicine, 2Human Genetics, and 3Pathology, and 4Cancer Research Center, Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago; 5Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois; Departments of 6Oncology and Radiotherapy and 7Thoracic Surgery, Medical University of Gdansk, Gdansk, Poland; 8Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado; and 9Molecular Cell Biology, Paul Scherrer Institut, Villigen, Switzerland Authors' Affiliations: 1University of Pittsburgh Cancer Institute, Pittsburgh; 2Penn State Hershey Cancer Institute, Hershey, Pennsylvania; 3Premiere Oncology, Santa Monica; 4City of Hope, Duarte, California; 5Synta Pharmaceuticals Corp., Lexington; 6Massachusetts General Hospital; 7Beth Israel Deaconess Medical Center; 8Dana-Farber Cancer Institute, Boston, Massachusetts; 9Vanderbilt Ingram Cancer Center, Nashville, Tennessee; 10Piedmont Hematology Oncology Associates, Winston-Salem, North Carolina; 11University of Chicago Medical Center; 12Rush University Medical Center, Chicago, Illinois; 13Swedish Cancer Center, Seattle, Washington; 14Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; 15Nevada Cancer Institute, Las Vegas, Nevada; 16OHSU, Knight Cancer Institute, Portland, Oregon; 17Genesis Cancer Center, Hot Springs, Arkansas; 18Hackensack University Medical Center, Hackensack, New Jersey; and 19Winship Cancer Institute, Emory University, Atlanta, Georgia Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA Professor, Department of Medicine, Section of Hematology/Oncology, Pritzker School of Medicine, The University of Chicago. Department of Medical Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA, USA Department of Medical Oncology and Therapeutics Research City of Hope Duarte California 1Section of Hematology/Oncology, Department of Medicine, Pritzker School of Medicine, University of Chicago Medical Center, Chicago, Illinois; Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA University of Chicago, Section of Hematology and Oncology, Pritzker Medical School, Chicago, IL, USA Department of Medicine, University of Chicago, USA Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA 2Section of Hematology/Oncology, Department of Medicine, University of Chicago and 6Medicine, University of Chicago Hospitals, Chicago, Illinois; and 4Department of Medicine, Division of Hematology/Oncology, University of Chicago, Chicago, Illinois. Department of Medical Oncology City of Hope National Medical Center Duarte CA USA Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA; Departments of Medical Oncology City of Hope National Medical Center and Comprehensive Cancer Center Duarte California 1Section of Hematology/Oncology, Department of Medicine and University of Chicago Cancer Research Center and City of Hope, Duarte, CA 91010, USA Department of Medical Oncology, Dana-Farber Cancer Institute;Department of Medicine, Brigham and Women’s Hospital and Harvard Medical Schoxol 7Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California. City of Hope Cancer Center, Duarte, CA Division of Adult Oncology and Thoracic Oncology Program, Department of Medicine, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School University of Chicago, Chicago, IL Daniel V.T. Catenacci, Theodore Karrison, James Wallace, Mark Kozloff, Peng Xu, Les Henderson, Ravi Salgia, Walter M. Stadler, Hedy L. Kindler, University of Chicago Medical Center; Patrick Stiff, Loyola University Medical Center, Chicago; Robert Marsh, Northshore University Health System, Evanston; James Wallace, Mark Kozloff, Ingalls Hospital, Harvey; James Wade, Decatur Memorial Hospital, Decatur; Pankaj Kumar, Oncology/Hematology Associates, Peoria, IL; Melissa R. Junttila, Xi Wang, and Frederic J.... From the Department of Neurology (R.V.L., K.R.), Section of Geriatrics and Palliative Medicine, Department of Medicine (M.M.), and Section of Hematology & Oncology, Department of Medicine (R.S.), University of Chicago, Chicago, IL. 3University of Chicago, Chicago, Illinois. City of Hope National Medical Center, Duarte, CA 5Department of Medical Oncology, City of Hope National Medical Center, Duarte, California. Authors' Affiliation: Departments of Hematology/Oncology and Pathology, University of Chicago Medical Center, Chicago, Illinois 4Medicine/Section of Hematology and Oncology and; 5Committee on Cancer Biology, University of Chicago, Chicago, Illinois; From the Department of Medical Oncology and Department of Cancer Biology, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Department of Medical Oncology and Therapeutics Research, City of Hope, and Beckman Research Institute, Duarte, CA Department of Medical Oncology and Therapeutic Research, Beckman Research Institute, City of Hope Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA Department of Medical Oncology and Therapeutics, City of Hope, Duarte, CA, USA Department of Medicine, Section of Hematology/Oncology, University of Chicago, United States of America Department of Medicine, University of Chicago, Chicago, Illinois Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA. Department of Medical Oncology & Therapeutics Research City of Hope National Medical Center Duarte CA Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California. From The University of Texas MD Anderson Cancer Center, Houston, TX; University of Chicago, Chicago, IL; Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; Memorial Sloan-Kettering Cancer Center, New York, NY; School of Medicine, Shanghai Jiao Tong University, Shanghai, China; and Exelixis, South San Francisco, CA. Department of Adult Oncology, Dana-Farber Cancer Institute;Department of Medicine, Brigham and Women’ s Hospital and Harvard Medical School Sections of Gastroenterology and Hematology/Oncology, Departments of Medicine, Radiology, and Pathology, University of Chicago Medical Center and University of Chicago Cancer Research Center, Chicago, Illinois Departments of Adult Oncology and Biostatistics, Dana–Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115; and Department of Medicine, Division of Hematology–Oncology, and Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 4The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA. Department of Medicine, The University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, U.S.A. City of Hope Comprehensive Cancer Center Duarte California Authors' Affiliations: 1Department of Medicine; 2Comprehensive Cancer Center, and 3Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, Illinois; 4Department of Pharmacology, National Cheng Kung University, Tainan, Taiwan, Republic of China; Authors' Affiliations: 1Department of Medicine; 2Comprehensive Cancer Center, and 3Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, Illinois; 4Department of Pharmacology, National Cheng Kung University, Tainan, Taiwan, Republic of China Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, Pritzker School of MedicineChicago, Illinois From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Rocky Mountain Cancer Centers, Denver, CO; Christie Hospital National Health Service Foundation Trust, Manchester, United Kingdom; St Joseph Oncology, St Joseph, MO; New York Oncology Hematology, Albany, NY; Cancer Centers of Florida, Orlando, FL; Virginia Oncology Associates, Norfolk, VA; Sarah Cannon Research Institute, Nashville, TN; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; State University of... 5Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California. Section of Hematology, Oncology,University of Chicago Medical Center, Pritkzer School of Medicine,5841 S Maryland Ave, MC 2115, Chicago, Il 60637, USA. Authors' Affiliations: 1Department of Medicine, Section of Hematology/Oncology and 2Department of Pathology, University of Chicago, Chicago, Illinois; and 3Genentech, Inc., South San Francisco, California Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. rsalgia@coh.org. From the Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA Authors' Affiliations: 1Section of Hematology/Oncology, Department of Medicine; 2Pritzker School of Medicine; 3Department of Pathology, The University of Chicago, Chicago, Illinois; 4OncoplexDx, Rockville, Maryland; 5Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin; and 6Center for Molecular Stress Response, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts Department of Medical Oncology & Therapeutics Research, City of Hope, 1500 East Duarte Rd, Duarte, CA 91010, USA Department of Medicine, The University of Chicago, Chicago, IL 60637, USA Department of Medical Oncology & Molecular Therapeutics, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA From the Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH; City of Hope Comprehensive Cancer Center, Duarte, CA. Department of Medical Oncology & Therapeutics Research, The City of Hope, Duarte, CA 91010, USA Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA Dana-Farber Cancer Institute, Brigham & Women’s Hospital, and Harvard Medical School, Boston, MA Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA 7University of Chicago, Chicago, Texas. Federico Innocenti, Richard L. Schilsky, Jacqueline Ramírez, Linda Janisch, Samir Undevia, Larry K. House, Soma Das, Kehua Wu, Michelle Turcich, Theodore Karrison, Michael L. Maitland, Ravi Salgia, and Mark J. Ratain, University of Chicago, Chicago; and Robert Marsh, NorthShore University Health System, Evanston, IL. Department of Medicine University of Chicago Chicago IL USA; Comprehensive Cancer Center University of Chicago Chicago IL USA Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California. rsalgia@coh.org. 4City of Hope, Duarte, California. University of Chicago, Department of Medicine, Section of Hematology/Oncology, and University of Chicago Cancer Research Center, 5841 S Maryland Avenue, Chicago, IL 60637, USA. Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California 91010, United States 1Section of Hematology/Oncology, Department of Medicine, and Beth-Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Brigham & Women’s Hospital, and, Harvard Medical School, Boston, MA Department of Medical Oncology Beckman Research Institute of City of Hope Comprehensive Cancer Center and National Medical Center Duarte California Medical Oncology, City of Hope National Medical Center, Duarte, CA Thoracic Oncology Research Program, Department of Medicine, Section of Hematology and Oncology, University of Chicago, USA. Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, CA 1Section of Hematology/Oncology, Department of Medicine; City of Hope Comprehensive Cancer Center, Department of Medical Oncology & Research Therapeutics, 1500 E Duarte Road, Duarte, CA 91010, USA Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, USA Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA City of Hope, Department of Medical Oncology and Therapeutics Research, Duarte, California. Department of Medicine-Section of Hematology & Oncology, University of Chicago, Chicago, IL Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA. Department of Medical Oncology, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA From the Departments of Adult Oncology, Surgery, and Biostatistics, Dana-Farber Cancer Institute; Departments of Adult Oncology and Surgery, Brigham and Women’s Hospital; Departments of Adult Oncology, Surgery, Biostatistics, Genetics, Pathology, and Medicine, Division of Hematology-Oncology, and Children’s Hospital, Harvard Medical School; Departments of Surgery, Medicine, and Pathology, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA; and Cell Genesys, Foster City, CA. From the Department of Medicine, Department of Cancer Biology, Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN; Department of Internal Medicine, Duke University Medical Center, Durham, NC; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA. Department of Medicine The University of Chicago Chicago IL USA From the Department of Adult Oncology, Dana-Farber Cancer Institute, and the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Department of MedicineUniversity of ChicagoChicago, Illinois Department of Medicine University of Chicago Chicago Illinois USA City of Hope, Department of Medical Oncology and Therapeutics Research, Duarte 91010, CA, USA Authors' Affiliations: Departments of 1Medicine and 2Surgery, The University of Chicago; and 3Department of Bioengineering, SEO, MC 063, University of Illinois at Chicago, Chicago, Illinois; 4Department of Medicine, Medical Oncology, Dana-Farber Cancer Institute, and 5Department of Medicine, Harvard Medical School, Boston, Massachusetts; 6University Hospitals of Case Medical Center, Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, Case Comprehensive Cancer Center, Cleveland, Ohio; 7Departement of Internal Medicine, Comprehensive Cancer Center at the University of Michigan, Ann Arbor, Michigan; 8Hamon Center for Therapeutic Oncology Research, University of Texas, Southwestern Medical Center, Dallas, Texas; 9Ingalls Memorial Hospital, Harvey, Illinois; and 10Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan 3City of Hope, Duarte, California. All authors: University of Chicago, Chicago, IL. |
Incoming Links
Total number of triples: 587.